Arizona: 10:15 am, PX-SP-03-249/SC-RB-01-149J
Eau Claire: 12:15 pm, Amalia Conf Rm
Rochester: 12:15 pm, Geffen Aud/Fr M17
Florida: 1:15 pm, JA-VS-01-121N

Visiting Faculty
Timothy Miller, M.D., Ph.D.
Washington University
"An RNA-Targeted Therapeutic Strategy for ALS"

Learning objectives:
Review mechanism of action and delivery methods for antisense oligonucleotides
Review how to measure protein turn over rates in human cerebral spinal fluid
Recognize that there are genetic subsets of ALS that may have different mechanisms of disease and focused therapeutic strategies

The presenter (and/or spouse/partner) has the following relevant financial relationships to disclose:
Consultant - Biogen Idec; Grant/Research Support - Biogen Idec, Ionis Pharmaceuticals
The presenter does not intend to discuss an off-label/investigative use of a commercial product/device.